Skip to content
112112112

Drawing based on the label description. No photo yet.

“Moxifloxacin hydrochloride tablets 400 mg are available as Beige colored, capsule shaped, biconvex tablets debossed '112' on one side and plain on other side”

112 pill

Pill with imprint 112 is orange, capsule, 19 mm and has been identified as Moxifloxacin 400 mg. It is used for bronchitis, sinus infections and urinary tract infections (UTIs). It is supplied by Redpharm Drug, Inc.

Moxifloxacin 400 mg

Imprint
112
Strength
400 mg
Used for
Bronchitis, sinus infections and urinary tract infections (UTIs)
Color
Orange
Shape
Capsule / oblong
Size
19 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Redpharm Drug, Inc
Drug class
Antibiotic (fluoroquinolone)
NDC
67296-1679, 55111-112, 67296-1679-5, 55111-112-30, 55111-112-01, 55111-112-05, 55111-112-79, 55111-112-66, 53002-2723, 53002-2723-7, 53002-2723-1, 63629-8357, 63629-8357-1, 63629-8357-2, 72789-233, 72789-233-10

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Moxifloxacin pills and guides

What is Moxifloxacin used for?

Moxifloxacin is used for bronchitis, sinus infections, urinary tract infections (UTIs) and pneumonia.

Medicine type
Antibiotic (fluoroquinolone)
Official uses from the US prescribing label

Community Acquired Pneumonia

Moxifloxacin tablets are indicated in adult patients for the treatment of Community Acquired Pneumonia caused by susceptible isolates of Streptococcus pneumoniae(including multi-drug resistant Streptococcus pneumoniae[MDRSP]), Haemophilus influenzae, Moraxella catarrhalis,methicillin-susceptible Staphylococcus aureus, Klebsiella pneumoniae, Mycoplasma pneumoniae,or Chlamydophila pneumoniae.

MDRSP isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [MIC] ≥ 2 mcg/mL), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole.

Uncomplicated Skin and Skin Structure Infections

Moxifloxacin tablets are indicated in adult patients for the treatment of Uncomplicated Skin and Skin Structure Infections caused by susceptible isolates of methicillin-susceptible Staphylococcus aureusor Streptococcus pyogenes.

Complicated Skin and Skin Structure Infections

Moxifloxacin tablets are indicated in adult patients for the treatment of Complicated Skin and Skin Structure Infections caused by susceptible isolates of methicillin-susceptible Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae,or Enterobacter cloacae.

Complicated Intra-Abdominal Infections

Moxifloxacin tablets are indicated in adult patients for the treatment of Complicated Intra-Abdominal Infections (cIAI) including polymicrobial infections such as abscess caused by susceptible isolates of Escherichia coli, Bacteroides fragilis, Streptococcus anginosus, Streptococcus constellatus, Enterococcus faecalis, Proteus mirabilis, Clostridium perfringens, Bacteroides thetaiotaomicron,or Peptostreptococcusspecies.

Plague

Moxifloxacin tablets are indicated in adult patients for the treatment of plague, including pneumonic and septicemic plague, due to susceptible isolates of Yersinia pestisand prophylaxis of plague in adult patients. Efficacy studies of moxifloxacin could not be conducted in humans with plague for feasibility reasons. Therefore, this indication is based on an efficacy study conducted in animals only.

Acute Bacterial Sinusitis

Moxifloxacin tablets are indicated in adult patients for the treatment of acute bacterial sinusitis (ABS) caused by susceptible isolates of Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis.

Because fluoroquinolones, including moxifloxacin tablets, have been associated with serious adverse reactions and for some patients ABS is self-limiting, reserve moxifloxacin tablets for treatment of ABS in patients who have no alternative treatment options.

Acute Bacterial Exacerbation of Chronic Bronchitis

Moxifloxacin tablets are indicated in adult patients for the treatment of Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB) caused by susceptible isolates of Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae,methicillin-susceptible Staphylococcus aureus,or Moraxella catarrhalis.

Because fluoroquinolones, including moxifloxacin tablets, have been associated with serious adverse reactions and for some patients ABECB is self-limiting, reserve moxifloxacin tablets for treatment of ABECB in patients who have no alternative treatment options.

Usage

To reduce the development of drug-resistant bacteria and maintain the effectiveness of moxifloxacin tablets and other antibacterial drugs, moxifloxacin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

From the FDA-approved label on DailyMed (published Sep 14, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows 112 and the other side is plain.
  • It is orange, capsule, 19 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Moxifloxacin Hydrochloride

Inactive: Silicon Dioxide, Croscarmellose Sodium, Hypromellose 2910 (3 Mpa.s), Hypromellose 2910 (6 Mpa.s), Ferric Oxide Red, Ferric Oxide Yellow, Magnesium Stearate, Cellulose, Microcrystalline, Polyethylene Glycol 400, Polysorbate 80, Sodium Stearyl Fumarate, Talc, Titanium Dioxide

Also distributed by

Dr. Reddy's Laboratories Limited, Rpk Pharmaceuticals, Inc., Bryant Ranch Prepack, Pd-Rx Pharmaceuticals, Inc.

Other pills with imprint 112

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Moxifloxacin pills